Vaccines -- Canada : Public health in the age of anxiety : religious and cultural roots of vaccine hesitancy in Canada / edited by Paul Bramadat, Maryse Guay, Julie A. Bettinger, and Réal Roy
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced
1
Vaccines -- Case studies : Moderna Inc. and the future of vaccine technologies : management and protection of intellectual property / Alan Trinh
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified
Vaccines -- Congresses -- adverse effects : Research strategies for assessing adverse events associated with vaccines : a workshop summary / Committee to Study New Research on Vaccines, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Vaccines, DNA -- administration & dosage. : DNA pharmaceuticals : formulation and delivery in gene therapy, DNA vaccination and immunotherapy / edited by Martin Schleef
Vaccines -- Guideline -- United States : Priorities for the national vaccine plan / Committee on Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS
